Clinical evaluation of the effect on oral administration of peenisa chooranam in the management of sinusitis

Clinical evaluation of the effect on oral administration of peenisa chooranam in the management of slethumapeenisam

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2020/12/029756

Enrollment

Registered

2020-12-11

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J01- Acute sinusitis

Interventions

Intervention1: Peenisa chooranam: Should be administered orally two times a day after food along with honey for a period of 14 days dose:500mg Control Intervention1: NOT APPLICABLE : NOT APPLICABLE

Eligibility

Inclusion criteria

Inclusion criteria: 1.Nasal congestion 2.purulent and watery discharge 3.cough and sneezing

Exclusion criteria

Exclusion criteria: 1.severe and recurrent epistaxis due to sinusitis 2.TB rhinitis 3.Rhinosporidiasis 4.Malignancy related sinusitis

Design outcomes

Primary

Measure	Time frame
Reducing nasal congestion,purulent and watery nasal discharge,pain and tenderness around the nose,orbit and maxillary region,cough and sneezingTimepoint: 1 week	—

Secondary

Measure	Time frame
Assessed by SNOT-22Timepoint: 2 weeks	—

Countries

India

Contacts

Public ContactD k Soundararajan

Government siddha medical college and hospital,palayamkottai

dr.dks.2012@gmail.com9442048801

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026